APO RESEARCH · REPORT
Women's Health
This report focuses on pharmaceutical products for female-related diseases.
Product & engineering
Understand the product.
This report focuses on pharmaceutical products for female-related diseases.
Selected research
Industry Research
Women's Health Industry Research Report 2026
Market perspective
This report focuses on pharmaceutical products for female-related diseases.
The main companies of Global Women's Health include Amgen, Bayer, Merck KGaA, etc. These top three companies hold a market share about 20%. Europe and North America are the leading production regions in the world. The product is mainly used in contraceptive pills.
Report Scope
Read the full market overview
This report quantifies the global Women's Health market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Women's Health.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Women's Health Market by Company
Amgen
Bayer
Merck KGaA
Merck & Co
Ferring
Eli Lilly
Pfizer
AbbVie
Abbott
Theramex
Livzon Pharmaceutical Group
Foundation Consumer Healthcare
Zhejiang Xianju Pharmaceutical
Zizhu Pharmaceutical
Qianjin Pharmaceutical
Women's Health Segment by Type
Hormone Therapy
Nonhormonal Therapy
Women's Health Segment by Application
Climacteric
Postmenopausal Osteoporosis
Contraceptive Pill
Infertility
Others
Women's Health Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Women's Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Women's Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Women's Health.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Women's Health companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hormone Therapy
- Nonhormonal Therapy
Applications
- Climacteric
- Postmenopausal Osteoporosis
- Contraceptive Pill
- Infertility
- Others
Companies covered
- Amgen
- Bayer
- Merck KGaA
- Merck & Co
- Ferring
- Eli Lilly
- Pfizer
- AbbVie
- Abbott
- Theramex
- Livzon Pharmaceutical Group
- Foundation Consumer Healthcare
- Zhejiang Xianju Pharmaceutical
- Zizhu Pharmaceutical
- Qianjin Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Women's Health by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Hormone Therapy
- 2.2.3 Nonhormonal Therapy
- 2.3 Women's Health by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Climacteric
- 2.3.3 Postmenopausal Osteoporosis
- 2.3.4 Contraceptive Pill
- 2.3.5 Infertility
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Women's Health Breakdown Data by Type
- 3.1 Global Women's Health Historic Market Size by Type (2021-2026)
- 3.2 Global Women's Health Forecasted Market Size by Type (2027-2032)
4 Women's Health Breakdown Data by Application
- 4.1 Global Women's Health Historic Market Size by Application (2021-2026)
- 4.2 Global Women's Health Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Women's Health Market Perspective (2021-2032)
- 5.2 Global Women's Health Growth Trends by Region
- 5.2.1 Global Women's Health Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Women's Health Historic Market Size by Region (2021-2026)
- 5.2.3 Women's Health Forecasted Market Size by Region (2027-2032)
- 5.3 Women's Health Market Dynamics
- 5.3.1 Women's Health Industry Trends
- 5.3.2 Women's Health Market Drivers
- 5.3.3 Women's Health Market Challenges
- 5.3.4 Women's Health Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Women's Health Players by Revenue
- 6.1.1 Global Top Women's Health Players by Revenue (2021-2026)
- 6.1.2 Global Women's Health Revenue Market Share by Players (2021-2026)
- 6.2 Global Women's Health Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Women's Health Head Office and Area Served
- 6.4 Global Women's Health Players, Product Type & Application
- 6.5 Global Women's Health Manufacturers Established Date
- 6.6 Global Women's Health Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Women's Health Market Size (2021-2032)
- 7.2 North America Women's Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Women's Health Market Size by Country (2021-2026)
- 7.4 North America Women's Health Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Women's Health Market Size (2021-2032)
- 8.2 Europe Women's Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Women's Health Market Size by Country (2021-2026)
- 8.4 Europe Women's Health Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Women's Health Market Size (2021-2032)
- 9.2 Asia-Pacific Women's Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Women's Health Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Women's Health Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Women's Health Market Size (2021-2032)
- 10.2 South America Women's Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Women's Health Market Size by Country (2021-2026)
- 10.4 South America Women's Health Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Women's Health Market Size (2021-2032)
- 11.2 Middle East & Africa Women's Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Women's Health Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Women's Health Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Amgen
- 12.1.1 Amgen Company Information
- 12.1.2 Amgen Business Overview
- 12.1.3 Amgen Revenue in Women's Health Business (2021-2026)
- 12.1.4 Amgen Women's Health Product Portfolio
- 12.1.5 Amgen Recent Developments
- 12.2 Bayer
- 12.2.1 Bayer Company Information
- 12.2.2 Bayer Business Overview
- 12.2.3 Bayer Revenue in Women's Health Business (2021-2026)
- 12.2.4 Bayer Women's Health Product Portfolio
- 12.2.5 Bayer Recent Developments
- 12.3 Merck KGaA
- 12.3.1 Merck KGaA Company Information
- 12.3.2 Merck KGaA Business Overview
- 12.3.3 Merck KGaA Revenue in Women's Health Business (2021-2026)
- 12.3.4 Merck KGaA Women's Health Product Portfolio
- 12.3.5 Merck KGaA Recent Developments
- 12.4 Merck & Co
- 12.4.1 Merck & Co Company Information
- 12.4.2 Merck & Co Business Overview
- 12.4.3 Merck & Co Revenue in Women's Health Business (2021-2026)
- 12.4.4 Merck & Co Women's Health Product Portfolio
- 12.4.5 Merck & Co Recent Developments
- 12.5 Ferring
- 12.5.1 Ferring Company Information
- 12.5.2 Ferring Business Overview
- 12.5.3 Ferring Revenue in Women's Health Business (2021-2026)
- 12.5.4 Ferring Women's Health Product Portfolio
- 12.5.5 Ferring Recent Developments
- 12.6 Eli Lilly
- 12.6.1 Eli Lilly Company Information
- 12.6.2 Eli Lilly Business Overview
- 12.6.3 Eli Lilly Revenue in Women's Health Business (2021-2026)
- 12.6.4 Eli Lilly Women's Health Product Portfolio
- 12.6.5 Eli Lilly Recent Developments
- 12.7 Pfizer
- 12.7.1 Pfizer Company Information
- 12.7.2 Pfizer Business Overview
- 12.7.3 Pfizer Revenue in Women's Health Business (2021-2026)
- 12.7.4 Pfizer Women's Health Product Portfolio
- 12.7.5 Pfizer Recent Developments
- 12.8 AbbVie
- 12.8.1 AbbVie Company Information
- 12.8.2 AbbVie Business Overview
- 12.8.3 AbbVie Revenue in Women's Health Business (2021-2026)
- 12.8.4 AbbVie Women's Health Product Portfolio
- 12.8.5 AbbVie Recent Developments
- 12.9 Abbott
- 12.9.1 Abbott Company Information
- 12.9.2 Abbott Business Overview
- 12.9.3 Abbott Revenue in Women's Health Business (2021-2026)
- 12.9.4 Abbott Women's Health Product Portfolio
- 12.9.5 Abbott Recent Developments
- 12.10 Theramex
- 12.10.1 Theramex Company Information
- 12.10.2 Theramex Business Overview
- 12.10.3 Theramex Revenue in Women's Health Business (2021-2026)
- 12.10.4 Theramex Women's Health Product Portfolio
- 12.10.5 Theramex Recent Developments
- 12.11 Livzon Pharmaceutical Group
- 12.11.1 Livzon Pharmaceutical Group Company Information
- 12.11.2 Livzon Pharmaceutical Group Business Overview
- 12.11.3 Livzon Pharmaceutical Group Revenue in Women's Health Business (2021-2026)
- 12.11.4 Livzon Pharmaceutical Group Women's Health Product Portfolio
- 12.11.5 Livzon Pharmaceutical Group Recent Developments
- 12.12 Foundation Consumer Healthcare
- 12.12.1 Foundation Consumer Healthcare Company Information
- 12.12.2 Foundation Consumer Healthcare Business Overview
- 12.12.3 Foundation Consumer Healthcare Revenue in Women's Health Business (2021-2026)
- 12.12.4 Foundation Consumer Healthcare Women's Health Product Portfolio
- 12.12.5 Foundation Consumer Healthcare Recent Developments
- 12.13 Zhejiang Xianju Pharmaceutical
- 12.13.1 Zhejiang Xianju Pharmaceutical Company Information
- 12.13.2 Zhejiang Xianju Pharmaceutical Business Overview
- 12.13.3 Zhejiang Xianju Pharmaceutical Revenue in Women's Health Business (2021-2026)
- 12.13.4 Zhejiang Xianju Pharmaceutical Women's Health Product Portfolio
- 12.13.5 Zhejiang Xianju Pharmaceutical Recent Developments
- 12.14 Zizhu Pharmaceutical
- 12.14.1 Zizhu Pharmaceutical Company Information
- 12.14.2 Zizhu Pharmaceutical Business Overview
- 12.14.3 Zizhu Pharmaceutical Revenue in Women's Health Business (2021-2026)
- 12.14.4 Zizhu Pharmaceutical Women's Health Product Portfolio
- 12.14.5 Zizhu Pharmaceutical Recent Developments
- 12.15 Qianjin Pharmaceutical
- 12.15.1 Qianjin Pharmaceutical Company Information
- 12.15.2 Qianjin Pharmaceutical Business Overview
- 12.15.3 Qianjin Pharmaceutical Revenue in Women's Health Business (2021-2026)
- 12.15.4 Qianjin Pharmaceutical Women's Health Product Portfolio
- 12.15.5 Qianjin Pharmaceutical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst